TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of mycobacterial ...

An international research team headed by scientists at the University of British Columbia has demonstrated how a novel semi-synthetic compound derived from sanguinarine (SG), an alkaloid extracted ...

BENGALURU (Reuters) - Drugmaker Mylan NV said on Wednesday it has received Indian regulatory approval to make tuberculosis treatment pretomanid available in a country that accounts for a quarter of ...

In a recent study published in Scientific Reports, a group of researchers evaluated the effectiveness and safety of herbs and alternative medicines in preventing liver injury induced by ...

University of Dundee researchers have made a significant breakthrough in the global effort to combat tuberculosis.

Researchers have found that approved drugs that were originally shown to normalize blood vessels surrounding tumors (to improve drug delivery to cancer cells) can enhance the delivery of ...

IPC to develop IP Reference Standards for anti-TB medicine bedaquiline: Shardul Nautiyal, Mumbai Thursday, January 22, 2026, 08:00 Hrs [IST] In order to ensure quality and safe an ...